[HTML][HTML] Treatment strategies in inflammatory bowel diseases
A Stallmach, R Atreya, PC Grunert… - Deutsches Ärzteblatt …, 2023 - ncbi.nlm.nih.gov
Background The prevalence of inflammatory bowel disease (IBD) is rising globally. In
Germany, these conditions affect 0.7% of the population, or approximately 600 000 patients …
Germany, these conditions affect 0.7% of the population, or approximately 600 000 patients …
Exploring the Role of the Gut Microbiota on Host Response to Immune Checkpoint Blockade Treatment in Gnotobiotic Mice
KR Mead - 2023 - search.proquest.com
Immune checkpoint blockade (ICB) has shown immense potential as a therapeutic agent
against a range of solid and hematological malignancies. While boasting substantial tumor …
against a range of solid and hematological malignancies. While boasting substantial tumor …